N,N-dimethyl-N'-p-tolylsulfamide : A member of the class of sulfamides that is N,N-dimethylsulfuric diamide substituted by a 4-methylphenyl group at the amino nitrogen atom. It is a metabolite of the agrochemical tolylfluanid. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
| ID Source | ID |
|---|---|
| PubMed CID | 738302 |
| CHEMBL ID | 1458342 |
| CHEBI ID | 83470 |
| SCHEMBL ID | 3467606 |
| Synonym |
|---|
| MLS000067488 |
| smr000125003 |
| IDI1_015390 |
| AP-124/10330009 |
| n,n-dimethyl-n'-(4-methylphenyl)sulfamide |
| SR-01000635398-1 |
| MAYBRIDGE3_004003 |
| STK036039 |
| n,n-dimethyl-n'-(4-methylphenyl)sulfuric diamide |
| HMS1442F21 |
| 1-(dimethylsulfamoylamino)-4-methylbenzene |
| AKOS000646866 |
| 66840-71-9 |
| n,n-dimethyl-n'-p-tolylsulphamide |
| NCGC00245332-01 |
| ios7w692n5 , |
| unii-ios7w692n5 |
| einecs 266-491-0 |
| HMS2185F21 |
| CCG-45644 |
| F1196-0085 |
| SCHEMBL3467606 |
| CHEBI:83470 , |
| n,n-dimethyl-n'-p-tolylsulfamide |
| cambridge id 6182799 |
| n,n-dimethyl-n'-tolylsulfonyldiamide |
| dmst |
| CHEMBL1458342 |
| W-111276 |
| sulfamide, n,n-dimethyl-n'-(4-methylphenyl)- |
| 4-dimethylaminosulfotoluidide |
| dimethyl[(4-methylphenyl)sulfamoyl]amine |
| Z57744695 |
| dmst 100 microg/ml in acetonitrile |
| n.n-dimethyl-n'-p-tolylsulphamide |
| tolylfluanid tp |
| dmst (ii) |
| n,n-dimethyl-n'-p-tolysulphamide |
| DTXSID00891450 |
| Q27156853 |
| FT-0706683 |
| dimethyl-n-p-tolylsulfamide |
| n,n-dimethyl-n inverted exclamation marka-p-tolylsulfamide |
| CS-0331417 |
| Role | Description |
|---|---|
| marine xenobiotic metabolite | Any metabolite produced by metabolism of a xenobiotic compound in marine macro- and microorganisms. |
| [role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Class | Description |
|---|---|
| sulfamides | Compounds where two amino groups are bound to an SO2 unit. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Protein | Taxonomy | Measurement | Average (µ) | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
|---|---|---|---|---|---|---|---|
| Chain A, Beta-lactamase | Escherichia coli K-12 | Potency | 100.0000 | 0.0447 | 17.8581 | 100.0000 | AID485294 |
| Chain A, Ferritin light chain | Equus caballus (horse) | Potency | 56.2341 | 5.6234 | 17.2929 | 31.6228 | AID485281 |
| 67.9K protein | Vaccinia virus | Potency | 28.1838 | 0.0001 | 8.4406 | 100.0000 | AID720580 |
| 15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | Homo sapiens (human) | Potency | 39.8107 | 0.0018 | 15.6638 | 39.8107 | AID894 |
| Guanine nucleotide-binding protein G | Homo sapiens (human) | Potency | 11.2202 | 1.9953 | 25.5327 | 50.1187 | AID624287 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] | |||||||
| Process | via Protein(s) | Taxonomy |
|---|---|---|
| negative regulation of inflammatory response to antigenic stimulus | Guanine nucleotide-binding protein G | Homo sapiens (human) |
| renal water homeostasis | Guanine nucleotide-binding protein G | Homo sapiens (human) |
| G protein-coupled receptor signaling pathway | Guanine nucleotide-binding protein G | Homo sapiens (human) |
| regulation of insulin secretion | Guanine nucleotide-binding protein G | Homo sapiens (human) |
| cellular response to glucagon stimulus | Guanine nucleotide-binding protein G | Homo sapiens (human) |
| [Information is prepared from geneontology information from the June-17-2024 release] | ||
| Process | via Protein(s) | Taxonomy |
|---|---|---|
| G protein activity | Guanine nucleotide-binding protein G | Homo sapiens (human) |
| adenylate cyclase activator activity | Guanine nucleotide-binding protein G | Homo sapiens (human) |
| [Information is prepared from geneontology information from the June-17-2024 release] | ||
| Process | via Protein(s) | Taxonomy |
|---|---|---|
| plasma membrane | Guanine nucleotide-binding protein G | Homo sapiens (human) |
| [Information is prepared from geneontology information from the June-17-2024 release] | ||
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID1794808 | Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL). | 2014 | Journal of biomolecular screening, Jul, Volume: 19, Issue:6 | A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum. |
| AID1794808 | Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL). | |||
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5 | Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1 | High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5 | Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1 | High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5 | Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1 | High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID504812 | Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7 | A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
| AID651635 | Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression | |||
| AID1745845 | Primary qHTS for Inhibitors of ATXN expression | |||
| AID504810 | Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7 | A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
| AID1159607 | Screen for inhibitors of RMI FANCM (MM2) intereaction | 2016 | Journal of biomolecular screening, Jul, Volume: 21, Issue:6 | A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway. |
| AID1159537 | qHTS screening for TAG (triacylglycerol) accumulators in algae | 2017 | Plant physiology, Aug, Volume: 174, Issue:4 | Identification and Metabolite Profiling of Chemical Activators of Lipid Accumulation in Green Algae. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 9 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Substance | Description | Relationhip Strength | Studies | Trials | Classes | Roles |
|---|---|---|---|---|---|---|
| levoplast | [no description available] | medium | 1 | 0 | C-nitro compound | |
| hippuric acid | [no description available] | medium | 1 | 0 | N-acylglycine | human blood serum metabolite; uremic toxin |
| xanthine | [no description available] | medium | 1 | 0 | xanthine | Saccharomyces cerevisiae metabolite |
| atrolactic acid | [no description available] | medium | 1 | 0 | 2-hydroxy monocarboxylic acid | |
| etofylline | [no description available] | medium | 1 | 0 | oxopurine | |
| n-acetyltryptophan | [no description available] | medium | 1 | 0 | N-acetyl-amino acid; tryptophan derivative | metabolite |
| ethacridine | [no description available] | medium | 1 | 0 | acridines | |
| altretamine | [no description available] | medium | 1 | 0 | triamino-1,3,5-triazine | |
| 2,5-di-tert-butylhydroquinone | [no description available] | medium | 1 | 0 | hydroquinones | |
| cx546 | [no description available] | medium | 1 | 0 | ||
| diphenhydramine | [no description available] | medium | 1 | 0 | ether; tertiary amino compound | anti-allergic agent; antidyskinesia agent; antiemetic; antiparkinson drug; antipruritic drug; antitussive; H1-receptor antagonist; local anaesthetic; muscarinic antagonist; oneirogen; sedative |
| diuron | [no description available] | medium | 1 | 0 | 3-(3,4-substituted-phenyl)-1,1-dimethylurea; dichlorobenzene | environmental contaminant; mitochondrial respiratory-chain inhibitor; photosystem-II inhibitor; urea herbicide; xenobiotic |
| ibuprofen | [no description available] | medium | 1 | 0 | monocarboxylic acid | antipyretic; cyclooxygenase 1 inhibitor; cyclooxygenase 2 inhibitor; drug allergen; environmental contaminant; geroprotector; non-narcotic analgesic; non-steroidal anti-inflammatory drug; radical scavenger; xenobiotic |
| ipriflavone | [no description available] | medium | 1 | 0 | aromatic ether; isoflavones | bone density conservation agent |
| mebendazole | [no description available] | medium | 1 | 0 | aromatic ketone; benzimidazoles; carbamate ester | antinematodal drug; microtubule-destabilising agent; tubulin modulator |
| nocodazole | [no description available] | medium | 1 | 0 | aromatic ketone; benzimidazoles; carbamate ester; thiophenes | antimitotic; antineoplastic agent; microtubule-destabilising agent; tubulin modulator |
| piribedil | [no description available] | medium | 1 | 0 | N-arylpiperazine | |
| procainamide | [no description available] | medium | 1 | 0 | benzamides | anti-arrhythmia drug; platelet aggregation inhibitor; sodium channel blocker |
| prometone | [no description available] | medium | 1 | 0 | diamino-1,3,5-triazine; methoxy-1,3,5-triazine | environmental contaminant; herbicide; xenobiotic |
| propanil | [no description available] | medium | 1 | 0 | anilide; dichlorobenzene | herbicide |
| sulfadimethoxine | [no description available] | medium | 1 | 0 | aromatic ether; pyrimidines; substituted aniline; sulfonamide antibiotic; sulfonamide | antiinfective agent; antimicrobial agent; drug allergen; environmental contaminant; xenobiotic |
| sulfamethazine | [no description available] | medium | 1 | 0 | pyrimidines; sulfonamide antibiotic; sulfonamide | antibacterial drug; antiinfective agent; antimicrobial agent; carcinogenic agent; drug allergen; EC 2.5.1.15 (dihydropteroate synthase) inhibitor; environmental contaminant; ligand; xenobiotic |
| sulfathiazole | [no description available] | medium | 1 | 0 | 1,3-thiazoles; substituted aniline; sulfonamide antibiotic; sulfonamide | antiinfective agent; drug allergen; EC 2.5.1.15 (dihydropteroate synthase) inhibitor; environmental contaminant; xenobiotic |
| testosterone | [no description available] | medium | 1 | 0 | 3-hydroxy steroid | androgen |
| 2-hydroxybenzylbenzimidazole | [no description available] | medium | 1 | 0 | ||
| etimizol | [no description available] | medium | 1 | 0 | ||
| nifenalol | [no description available] | medium | 1 | 0 | C-nitro compound | |
| bis(4-hydroxyphenyl)sulfone | [no description available] | medium | 1 | 0 | bisphenol; sulfone | endocrine disruptor; metabolite |
| 8-hydroxyquinoline-5-sulfonic acid | [no description available] | medium | 1 | 0 | ||
| salicylanilide | [no description available] | medium | 1 | 0 | benzanilide fungicide; salicylamides; salicylanilides | |
| 2-phenylbutyric acid | [no description available] | medium | 1 | 0 | benzenes; monocarboxylic acid | human xenobiotic metabolite |
| 4,4'-dimethoxybenzophenone | [no description available] | medium | 1 | 0 | ||
| 6-phenyl-1,3,5-triazine-2,4-diamine | [no description available] | medium | 1 | 0 | ||
| quinaldic acid | [no description available] | medium | 1 | 0 | quinolinemonocarboxylic acid | human metabolite; Saccharomyces cerevisiae metabolite |
| N-(2-methoxyphenyl)acetamide | [no description available] | medium | 1 | 0 | acetamides; methoxybenzenes | |
| fast red b | [no description available] | medium | 1 | 0 | ||
| methylenebis(chloroaniline) | [no description available] | medium | 1 | 0 | chloroaniline | metabolite |
| di-(4-aminophenyl)ether | [no description available] | medium | 1 | 0 | aromatic ether | |
| diphenylguanidine | [no description available] | medium | 1 | 0 | guanidines | allergen |
| 4-Anilino-4-oxobutanoic acid | [no description available] | medium | 1 | 0 | anilide | |
| mephobarbital | [no description available] | medium | 1 | 0 | barbiturates | anticonvulsant |
| etryptamine | [no description available] | medium | 1 | 0 | indoles | |
| sulfacetamide | [no description available] | medium | 1 | 0 | ||
| cinchophen | [no description available] | medium | 1 | 0 | quinolines | |
| 2-aminobenzothiazole | [no description available] | medium | 1 | 0 | benzothiazoles | |
| carzenide | [no description available] | medium | 1 | 0 | sulfonamide | |
| nitrilotriacetic acid | [no description available] | medium | 1 | 0 | NTA; tricarboxylic acid | carcinogenic agent; nephrotoxic agent |
| n-(2-cyanoethyl)-2-phenylethylamine | [no description available] | medium | 1 | 0 | ||
| cyclooctane | [no description available] | medium | 1 | 0 | ||
| triphenyltetrazolium chloride | [no description available] | medium | 1 | 0 | organic chloride salt | dye; indicator |
| 2,7-diacetylaminofluorene | [no description available] | medium | 1 | 0 | ||
| 3,4-pyridinedicarboxylic acid | [no description available] | medium | 1 | 0 | pyridinedicarboxylic acid | |
| 4-(benzoylamino)-2-hydroxybenzoic acid | [no description available] | medium | 1 | 0 | benzamides | |
| tropic acid | [no description available] | medium | 1 | 0 | 3-hydroxy monocarboxylic acid | human xenobiotic metabolite |
| 8-hydroxy-7-iodo-5-quinolinesulfonic acid | [no description available] | medium | 1 | 0 | hydroxyquinoline | |
| 1-acetylisatin | [no description available] | medium | 1 | 0 | indoledione | |
| 4-cumylphenol | [no description available] | medium | 1 | 0 | diarylmethane | |
| 5-methylisatin | [no description available] | medium | 1 | 0 | ||
| 2-hydrazinobenzothiazole | [no description available] | medium | 1 | 0 | ||
| 1,2,3-trimethoxybenzene | [no description available] | medium | 1 | 0 | methoxybenzenes | plant metabolite |
| 2-amino-5-chlorobenzophenone | [no description available] | medium | 1 | 0 | ||
| diphenamid | [no description available] | medium | 1 | 0 | diarylmethane | |
| 4-(4-nitrobenzyl)pyridine | [no description available] | medium | 1 | 0 | ||
| 5-methyl-3-phenylisoxazole-4-carboxylic acid | [no description available] | medium | 1 | 0 | ||
| 2-acetylbenzofuran | [no description available] | medium | 1 | 0 | ||
| pyrazon | [no description available] | medium | 1 | 0 | benzenes; organochlorine compound; primary amino compound; pyridazinone | environmental contaminant; herbicide; xenobiotic |
| 2-amino-5-nitrobenzophenone | [no description available] | medium | 1 | 0 | ||
| (4-tert-Butyl-phenoxy)-acetic acid | [no description available] | medium | 1 | 0 | monocarboxylic acid | |
| lenacil | [no description available] | medium | 1 | 0 | cyclopentapyrimidine | agrochemical; environmental contaminant; herbicide; xenobiotic |
| chlordesmethyldiazepam | [no description available] | medium | 1 | 0 | benzodiazepine | |
| 2-amino-2',5-dichlorobenzophenone | [no description available] | medium | 1 | 0 | ||
| 2-(2'-hydroxyphenyl)benzimidazole | [no description available] | medium | 1 | 0 | ||
| 4-phthalimidobutyric acid | [no description available] | medium | 1 | 0 | ||
| azabutyrone | [no description available] | medium | 1 | 0 | ||
| 2-(2-hydroxyphenyl)benzothiazole | [no description available] | medium | 1 | 0 | benzothiazoles; phenols | geroprotector |
| 4,5-dichlorocatechol | [no description available] | medium | 1 | 0 | ||
| n-butylbenzenesulfonamide | [no description available] | medium | 1 | 0 | sulfonamide | neurotoxin; plant metabolite |
| 3-phenoxybenzoic acid | [no description available] | medium | 1 | 0 | phenoxybenzoic acid | human xenobiotic metabolite; marine xenobiotic metabolite |
| 2-(2-hydroxyethylmercapto)benzothiazole | [no description available] | medium | 1 | 0 | ||
| carboxin | [no description available] | medium | 1 | 0 | anilide fungicide; anilide; enamide; organosulfur heterocyclic compound; oxacycle; secondary carboxamide | antifungal agrochemical; EC 1.3.5.1 [succinate dehydrogenase (quinone)] inhibitor |
| meturin | [no description available] | medium | 1 | 0 | ||
| 2-bromo-N-phenylbenzamide | [no description available] | medium | 1 | 0 | benzamides | |
| 4-chlorohippuric acid | [no description available] | medium | 1 | 0 | ||
| 4-chlorophenoxyacetic acid | [no description available] | medium | 1 | 0 | chlorophenoxyacetic acid; monochlorobenzenes | phenoxy herbicide |
| 2,5-dichloro-1,4-phenylenediamine | [no description available] | medium | 1 | 0 | ||
| metribuzin | [no description available] | medium | 1 | 0 | 1,2,4-triazines; cyclic ketone; organic sulfide | agrochemical; environmental contaminant; herbicide; xenobiotic |
| 2,5-dimethyl-3-furancarboxanilide | [no description available] | medium | 1 | 0 | ||
| moricizine hydrochloride | [no description available] | medium | 1 | 0 | hydrochloride | anti-arrhythmia drug |
| 2-benzimidazolylguanidine | [no description available] | medium | 1 | 0 | aminoimidazole | |
| diflubenzuron | [no description available] | medium | 1 | 0 | benzoylurea insecticide; monochlorobenzenes | insect sterilant |
| pentafluorobenzoyl-n-phenylethylamine | [no description available] | medium | 1 | 0 | ||
| thidiazuron | [no description available] | medium | 1 | 0 | ureas | |
| phenthiazamine | [no description available] | medium | 1 | 0 | ||
| 5,5-diphenylbarbituric acid | [no description available] | medium | 1 | 0 | ||
| 3-acetamidobenzoic acid | [no description available] | medium | 1 | 0 | ||
| dazoxiben hydrochloride | [no description available] | medium | 1 | 0 | ||
| succinylsulfanilamide | [no description available] | medium | 1 | 0 | ||
| benzylaminopurine | [no description available] | medium | 1 | 0 | 6-aminopurines | cytokinin; plant metabolite |
| ciprofloxacin hydrochloride anhydrous | [no description available] | medium | 1 | 0 | hydrochloride | antibacterial drug; antiinfective agent; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; topoisomerase IV inhibitor |
| src-820 r | [no description available] | medium | 1 | 0 | ||
| n(4)-acetylsulfadiazine | [no description available] | medium | 1 | 0 | acetamides; pyrimidines; sulfonamide | marine xenobiotic metabolite |
| 4-nitro-alpha-acetylamino-beta-hydroxypropiophenone | [no description available] | medium | 1 | 0 | ||
| formetamide | [no description available] | medium | 1 | 0 | ||
| isbufylline | [no description available] | medium | 1 | 0 | ||
| phenylacetylglycine | [no description available] | medium | 1 | 0 | monocarboxylic acid amide; monocarboxylic acid; N-acylglycine | human metabolite; mouse metabolite |
| N-benzoylanthranilic acid | [no description available] | medium | 1 | 0 | amidobenzoic acid | |
| butinoline | [no description available] | medium | 1 | 0 | diarylmethane | |
| n-(2-carboxyphenyl)glycine | [no description available] | medium | 1 | 0 | ||
| n,n-dimethyl-4-anisidine | [no description available] | medium | 1 | 0 | ||
| n-benzoylpiperidine | [no description available] | medium | 1 | 0 | benzamides; N-acylpiperidine | |
| 2-phenylcyclopropanecarboxylic acid | [no description available] | medium | 1 | 0 | ||
| n-demethylantipyrine | [no description available] | medium | 1 | 0 | pyrazoles; ring assembly | |
| 3-(2-pyridyl)-5,6-diphenyl-1,2,4-triazine | [no description available] | medium | 1 | 0 | 1,2,4-triazines | |
| 2-amino-5-bromopyridine | [no description available] | medium | 1 | 0 | ||
| n-benzoylalanine, (dl-ala)-isomer | [no description available] | medium | 1 | 0 | alanine derivative; N-acyl-amino acid | metabolite |
| bicinchoninic acid | [no description available] | medium | 1 | 0 | ||
| betamipron | [no description available] | medium | 1 | 0 | organonitrogen compound; organooxygen compound | |
| benzoylpropionic acid | [no description available] | medium | 1 | 0 | 4-oxo monocarboxylic acid | hapten |
| Evoxine | [no description available] | medium | 1 | 0 | organic heterotricyclic compound; organonitrogen heterocyclic compound; oxacycle | |
| 1-methyl-1,2,3,4-tetrahydro-beta-carboline-3-carboxylic acid | [no description available] | medium | 1 | 0 | harmala alkaloid | |
| N-Benzylphthalimide | [no description available] | medium | 1 | 0 | isoindoles | |
| pyromellitic diimide | [no description available] | medium | 1 | 0 | ||
| 4'-bromosalicylanilide | [no description available] | medium | 1 | 0 | ||
| 2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane | [no description available] | medium | 1 | 0 | bisphenol | |
| terephthalamide | [no description available] | medium | 1 | 0 | benzenedicarboxamide | |
| 3(2h)-pyridazinone, 4-chloro-5-(dimethylamino)-2-phenyl- | [no description available] | medium | 1 | 0 | ||
| 2-nitrophenylacetic acid | [no description available] | medium | 1 | 0 | C-nitro compound; phenylacetic acids | |
| onychine | [no description available] | medium | 1 | 0 | ||
| 4'-methoxyflavone | [no description available] | medium | 1 | 0 | ether; flavonoids | |
| 1,3-diphenyl-2-aminopropane | [no description available] | medium | 1 | 0 | ||
| 2,2-diphenylpropionic acid | [no description available] | medium | 1 | 0 | ||
| 3,4-dimethoxyphenylacetamide | [no description available] | medium | 1 | 0 | ||
| 2-amino-5-bromobenzoic acid | [no description available] | medium | 1 | 0 | ||
| 2-(1H-benzimidazol-2-yl)aniline | [no description available] | medium | 1 | 0 | benzimidazoles; primary arylamine; substituted aniline | geroprotector |
| N-Acetylhomoveratrylamine | [no description available] | medium | 1 | 0 | acetamides | |
| 2-chlorobenzenesulfonamide | [no description available] | medium | 1 | 0 | ||
| 4-nitrophenyl dimethylcarbamate | [no description available] | medium | 1 | 0 | ||
| 8-(4-tolylsulfonylamino)quinoline | [no description available] | medium | 1 | 0 | sulfonamide | |
| 5-methoxyindole-3-carbaldehyde | [no description available] | medium | 1 | 0 | indoles | |
| 2-oxo-1,2-dihydroquinoline-4-carboxylic acid | [no description available] | medium | 1 | 0 | quinolinemonocarboxylic acid | |
| 6-methoxy-2,3,4,9-tetrahydropyrido[3,4-b]indol-1-one | [no description available] | medium | 1 | 0 | beta-carbolines | |
| pd 147953 | [no description available] | medium | 1 | 0 | ||
| fenozan | [no description available] | medium | 1 | 0 | ||
| 5-phenylbarbituric acid | [no description available] | medium | 1 | 0 | ||
| diethylpropion hydrochloride | [no description available] | medium | 1 | 0 | hydrochloride | appetite depressant |
| 1-(4'-nitrophenyl)-2-aminopropane-1,3-diol | [no description available] | medium | 1 | 0 | ||
| beta-hydroxyphenylalanine | [no description available] | medium | 1 | 0 | ||
| 3-(n-salicyloyl)amino-1,2,4-triazole | [no description available] | medium | 1 | 0 | ||
| 7-chloro-4-aminoquinoline | [no description available] | medium | 1 | 0 | aminoquinoline | |
| acridine-9-carboxylic acid | [no description available] | medium | 1 | 0 | ||
| 1-phenazinecarboxylic acid | [no description available] | medium | 1 | 0 | aromatic carboxylic acid; monocarboxylic acid; phenazines | antifungal agent; antimicrobial agent; bacterial metabolite |
| 4,5-diphenyl-1,5-dihydroimidazol-2-one | [no description available] | medium | 1 | 0 | stilbenoid | |
| 2-hydroxy-1,2-bis(methoxyphenyl)ethanone | [no description available] | medium | 1 | 0 | ||
| 4-methyl-N-(phenylmethyl)benzenesulfonamide | [no description available] | medium | 1 | 0 | sulfonamide | |
| 4-n-butylaminobenzoic acid | [no description available] | medium | 1 | 0 | aromatic amino acid | |
| fluoren-9-ol | [no description available] | medium | 1 | 0 | ||
| 1-(2-carboxyethyl)uracil | [no description available] | medium | 1 | 0 | ||
| 1-benzylindole | [no description available] | medium | 1 | 0 | ||
| 2,3-bis(2-pyridinyl)quinoxaline | [no description available] | medium | 1 | 0 | quinoxaline derivative | |
| 3,3',5,5'-tetrachlorobiphenyl-4,4'-diol | [no description available] | medium | 1 | 0 | dichlorobenzene; hydroxybiphenyls | |
| 5-nitro-2-(1-piperidinyl)pyridine | [no description available] | medium | 1 | 0 | C-nitro compound | |
| 2-amino-5,7-dimethyl-1,8-naphthyridine | [no description available] | medium | 1 | 0 | ||
| 5-benzyloxytryptophan | [no description available] | medium | 1 | 0 | ||
| 2,5-diethoxy-4-morpholinoaniline | [no description available] | medium | 1 | 0 | ||
| 3-hydroxy-3-phenacyloxindole | [no description available] | medium | 1 | 0 | ||
| carbobenzoxyphenylalanine, (dl-phe)-isomer | [no description available] | medium | 1 | 0 | ||
| gamma-fagarine | [no description available] | medium | 1 | 0 | organic heterotricyclic compound; organonitrogen heterocyclic compound; oxacycle | |
| 3-carboxymethyl-6-benzyl-2,5-diketopiperazine | [no description available] | medium | 1 | 0 | organonitrogen compound; organooxygen compound | |
| 4-fluorobenzenesulfonamide | [no description available] | medium | 1 | 0 | ||
| emoxypine succinate | [no description available] | medium | 1 | 0 | ||
| n-carbamyltryptophan | [no description available] | medium | 1 | 0 | ||
| 2,4,6-trimethoxyacetophenone | [no description available] | medium | 1 | 0 | ||
| 1-(2-hydroxyethyl)-3,5-diphenyl-1h-pyrazole | [no description available] | medium | 1 | 0 | ||
| 4-methyoxybenzoyl-n-glycine | [no description available] | medium | 1 | 0 | N-acylglycine | |
| 5-ethoxy-2-ethylmercaptobenzimidazole | [no description available] | medium | 1 | 0 | ||
| 5(6)-1(2h)-phthalazinonyl-4(1h)-benzimidazole-2-carbamate methyl ester | [no description available] | medium | 1 | 0 | ||
| n-phenyliminodiacetic acid | [no description available] | medium | 1 | 0 | ||
| teomorfolin | [no description available] | medium | 1 | 0 | ||
| 1-(1,3-benzodioxol-5-yl)-3-(1-piperidinyl)-1-propanone | [no description available] | medium | 1 | 0 | benzodioxoles | |
| n-(aminocarbonyl)-2-chlorobenzenesulfonamide | [no description available] | medium | 1 | 0 | ||
| 3-hydroxy-2-quinoxalinepropionic acid | [no description available] | medium | 1 | 0 | ||
| 8-(methylsulfonylamino)quinoline | [no description available] | medium | 1 | 0 | ||
| n(4)-acetylsulfamonomethoxine | [no description available] | medium | 1 | 0 | ||
| 8-(4-benzenesulfonylamino)quinoline | [no description available] | medium | 1 | 0 | ||
| methindione | [no description available] | medium | 1 | 0 | ||
| 3,4-dihydroxybenzophenone | [no description available] | medium | 1 | 0 | ||
| gamma-propanol | [no description available] | medium | 1 | 0 | ||
| 2-[(3-oxo-1-cyclohexenyl)amino]benzonitrile | [no description available] | medium | 1 | 0 | benzenes; nitrile | |
| isonicotinylamide gaba | [no description available] | medium | 1 | 0 | ||
| 5-fluorotryptamine monohydrochloride | [no description available] | medium | 1 | 0 | ||
| 4-iodo-n-(2-(4-morpholinyl)ethyl)benzamide | [no description available] | medium | 1 | 0 | ||
| 3-(hydroxyacetyl)indole | [no description available] | medium | 1 | 0 | indoles | |
| n-(4-aminophenylsulfonyl)morpholine | [no description available] | medium | 1 | 0 | ||
| 1H-indol-3-yl-(4-methoxyphenyl)methanone | [no description available] | medium | 1 | 0 | N-acylindole | |
| 2-amino-5-phenyl-1,3,4-thiadiazole | [no description available] | medium | 1 | 0 | ||
| N-(1-phenylethyl)acetamide | [no description available] | medium | 1 | 0 | acetamides; secondary carboxamide | |
| alpha-(trichloromethyl)-4-pyridineethanol | [no description available] | medium | 1 | 0 | pyridines | |
| ml 204 | [no description available] | medium | 1 | 0 | ||
| eudesmin | [no description available] | medium | 1 | 0 | ||
| 2-amino-4-methyl-3-nitropyridine | [no description available] | medium | 1 | 0 | ||
| 4,4-bis(hydroxymethyl)-2-phenyl-2-oxazoline | [no description available] | medium | 1 | 0 | ||
| n-acetylhistidine | [no description available] | medium | 1 | 0 | histidine derivative; N-acetyl-amino acid | |
| 1-(1-oxo-2-phenylethyl)-4-piperidinecarboxylic acid | [no description available] | medium | 1 | 0 | acetamides | |
| 1-(4-chlorophenyl)-3-(2-ethoxyphenyl)urea | [no description available] | medium | 1 | 0 | ureas | |
| 4-methoxyxanthone | [no description available] | medium | 1 | 0 | ||
| N-(4-nitrophenyl)-2-phenoxyacetamide | [no description available] | medium | 1 | 0 | C-nitro compound | |
| 1-phenylindolin-2-one | [no description available] | medium | 1 | 0 | ||
| 1-(benzenesulfonyl)indole | [no description available] | medium | 1 | 0 | sulfonamide | |
| 2,4,4,6-Tetramethyl-1,4-dihydro-3,5-pyridinedicarbonitrile | [no description available] | medium | 1 | 0 | dihydropyridine | |
| pifithrin mu | [no description available] | medium | 1 | 0 | benzenes | |
| 2-benzyloxybenzaldehyde | [no description available] | medium | 1 | 0 | ||
| 2-guanidine-4-methylquinazoline | [no description available] | medium | 1 | 0 | ||
| N-phenylcarbamic acid 2-phenoxyethyl ester | [no description available] | medium | 1 | 0 | carbamate ester | |
| 3,4-dihydro-2H-benzo[4,5]imidazo[2,1-b][1,3]thiazin-3-ol | [no description available] | medium | 1 | 0 | benzimidazoles | |
| mequindox | [no description available] | medium | 1 | 0 | ||
| N-[2-(dimethylamino)ethyl]-2,2-diphenylacetamide | [no description available] | medium | 1 | 0 | diarylmethane | |
| Girgensonine | [no description available] | medium | 1 | 0 | nitrile | |
| Dubinidine | [no description available] | medium | 1 | 0 | organic heterotricyclic compound; organonitrogen heterocyclic compound; oxacycle | |
| N-[4-(methanesulfonamido)phenyl]acetamide | [no description available] | medium | 1 | 0 | sulfonamide | |
| 4-(2-oxazolo[4,5-b]pyridinyl)aniline | [no description available] | medium | 1 | 0 | 1,3-oxazoles | |
| 2-[(4-nitrophenyl)methylthio]-1,3-benzoxazole | [no description available] | medium | 1 | 0 | benzoxazole | |
| 3-oxido-4,5-dihydro-[1,2,5]oxadiazolo[3,4-f]cinnolin-3-ium | [no description available] | medium | 1 | 0 | pyridazines | |
| 3-(2,4-difluoroanilino)-5,5-dimethyl-1-cyclohex-2-enone | [no description available] | medium | 1 | 0 | substituted aniline | |
| 1-phenyl-4-pyrazolol | [no description available] | medium | 1 | 0 | pyrazoles; ring assembly | |
| 3-(3,5-dimethyl-1-pyrazolyl)-1,2-benzothiazole 1,1-dioxide | [no description available] | medium | 1 | 0 | benzothiazoles | |
| 3-benzamido-2-benzofurancarboxamide | [no description available] | medium | 1 | 0 | benzofurans | |
| N-[2-(4-methoxyphenyl)ethyl]acetamide | [no description available] | medium | 1 | 0 | acetamides | |
| N-[2-(3-methylphenoxy)ethyl]-1H-1,2,4-triazole-5-carboxamide | [no description available] | medium | 1 | 0 | aromatic ether | |
| 2-(1H-indol-3-ylthio)acetic acid | [no description available] | medium | 1 | 0 | indoles | |
| 3-bromo-N-[2-(4-nitroanilino)ethyl]benzamide | [no description available] | medium | 1 | 0 | carbonyl compound; organohalogen compound | |
| 3-Methylbenzofuran-2-carboxylic acid | [no description available] | medium | 1 | 0 | benzofurans | |
| 5-(3,4-dimethoxyphenyl)-2H-tetrazole | [no description available] | medium | 1 | 0 | tetrazoles | |
| 1-(4-fluorophenyl)sulfonyl-4-(2-methoxyphenyl)piperazine | [no description available] | medium | 1 | 0 | piperazines | |
| 4-[[bis(2-hydroxyethyl)amino]methyl]-2,6-ditert-butylphenol | [no description available] | medium | 1 | 0 | alkylbenzene | |
| 2-phenylindole-3-carbaldehyde | [no description available] | medium | 1 | 0 | ||
| 4-(2-pyridinylthio)benzofuro[3,2-d]pyrimidine | [no description available] | medium | 1 | 0 | aryl sulfide | |
| 5-(4-nitrophenyl)-4-phenyl-2-thiazolamine | [no description available] | medium | 1 | 0 | C-nitro compound | |
| 3-[6-(4-aminophenyl)-2-phenyl-4-pyrimidinyl]aniline | [no description available] | medium | 1 | 0 | pyrimidines | |
| 7-methoxyisoflavone | [no description available] | medium | 1 | 0 | 7-methoxyisoflavones | |
| LSM-32392 | [no description available] | medium | 1 | 0 | monoterpenoid | |
| N-[2-(1-cyclohexenyl)ethyl]-4-(4-morpholinylmethyl)benzamide | [no description available] | medium | 1 | 0 | benzamides | |
| 1-(1-benzimidazolyl)-3-(1-cyclohex-3-enylmethoxy)-2-propanol | [no description available] | medium | 1 | 0 | benzimidazoles | |
| N-[2-(2-furanylmethylthio)ethyl]-4-methoxybenzenesulfonamide | [no description available] | medium | 1 | 0 | sulfonamide | |
| 3-acetamido-5-chloro-2-benzofurancarboxylic acid | [no description available] | medium | 1 | 0 | benzofurans | |
| [4-(1,3-benzodioxol-5-ylmethyl)-1-piperazinyl]-(2,6-dimethoxyphenyl)methanone | [no description available] | medium | 1 | 0 | dimethoxybenzene | |
| 4-[4-methyl-6-(4-methyl-1-piperazinyl)-2-pyrimidinyl]morpholine | [no description available] | medium | 1 | 0 | N-arylpiperazine | |
| haplamine | [no description available] | medium | 1 | 0 | organic heterotricyclic compound; organonitrogen heterocyclic compound; oxacycle | |
| 5-(3,4-dimethoxyphenyl)-1H-1,2,4-triazol-3-amine | [no description available] | medium | 1 | 0 | triazoles | |
| 2-ethoxy-N-[4-(4-morpholinylsulfonyl)phenyl]benzamide | [no description available] | medium | 1 | 0 | benzamides | |
| 2-[(5-methyl-1H-1,2,4-triazol-3-yl)thio]-1-phenylethanone | [no description available] | medium | 1 | 0 | aromatic ketone | |
| 1-ethyl-6-methoxy-4-oxo-3-quinolinecarboxylic acid | [no description available] | medium | 1 | 0 | quinolines | |
| 2-(pyridin-4-yl)-4-(pyrrolidin-1-yl)quinazoline | [no description available] | medium | 1 | 0 | pyridines; pyrrolidines; quinazolines | |
| scp 1 | [no description available] | medium | 1 | 0 | ||
| N-(3-acetamidophenyl)-4-methoxybenzamide | [no description available] | medium | 1 | 0 | benzamides | |
| N-(3-acetamidophenyl)-3-chlorobenzamide | [no description available] | medium | 1 | 0 | benzamides | |
| 4-methoxy-N-(5-methyl-3-isoxazolyl)benzamide | [no description available] | medium | 1 | 0 | benzamides | |
| N-(2-fluorophenyl)-4-phenylmethoxybenzamide | [no description available] | medium | 1 | 0 | benzamides | |
| N-[4-(diethylamino)phenyl]-2-furancarboxamide | [no description available] | medium | 1 | 0 | aromatic amide; furans | |
| N-(2-furanylmethyl)-2-benzofurancarboxamide | [no description available] | medium | 1 | 0 | benzofurans | |
| 5-(2-phenylethyl)-1,3,4-thiadiazol-2-amine | [no description available] | medium | 1 | 0 | aromatic amine; thiadiazoles | |
| te 5 | [no description available] | medium | 1 | 0 | ||
| 2-[[anilino(oxo)methyl]amino]-4,5-dimethyl-3-thiophenecarboxamide | [no description available] | medium | 1 | 0 | ureas | |
| N-(4,6-dimethyl-2-pyrimidinyl)-1,3-benzothiazol-2-amine | [no description available] | medium | 1 | 0 | benzothiazoles | |
| 6-methylflavone | [no description available] | medium | 1 | 0 | ||
| 2-methoxy-N-(2-pyridinyl)benzamide | [no description available] | medium | 1 | 0 | benzamides | |
| 2-chloro-N-(2-phenylethyl)benzamide | [no description available] | medium | 1 | 0 | carbonyl compound; organohalogen compound | |
| N1-(4H-1,2,4-triazol-4-yl)-4-nitrobenzamide | [no description available] | medium | 1 | 0 | C-nitro compound | |
| N-[2-(1-cyclohexenyl)ethyl]-4-fluorobenzamide | [no description available] | medium | 1 | 0 | carbonyl compound; organohalogen compound | |
| tioxazafen | [no description available] | medium | 1 | 0 | 1,2,4-oxadiazole; thiophenes | agrochemical; nematicide |
| N-[5-(2-methylpropyl)-1,3,4-thiadiazol-2-yl]-2-thiophen-2-ylacetamide | [no description available] | medium | 1 | 0 | aromatic amide | |
| 1-(4-Methoxyphenyl)-2-nitroethylene | [no description available] | medium | 1 | 0 | methoxybenzenes | |
| brd32048 | [no description available] | medium | 1 | 0 | methoxybenzenes; substituted aniline | |
| 2-(4-chloro-3-methylphenoxy)-N-(1H-1,2,4-triazol-5-yl)acetamide | [no description available] | medium | 1 | 0 | aromatic ether | |
| 2-(3,4-dichlorophenyl)imidazo[1,2-a]pyrimidine | [no description available] | medium | 1 | 0 | imidazoles | |
| 5-(2-phenyl-4-triazolyl)-2H-tetrazole | [no description available] | medium | 1 | 0 | triazoles | |
| N-cyclohexyl-2,3-dihydroindole-1-carboxamide | [no description available] | medium | 1 | 0 | indolyl carboxylic acid | |
| 4-(benzylsulfanyl)thieno[2,3-d]pyrimidine | [no description available] | medium | 1 | 0 | aryl sulfide; benzenes; thienopyrimidine | |
| 2-methyl-5-(5-methyl-2-furanyl)-3-(1-pyrrolyl)-4-thieno[2,3-d]pyrimidinone | [no description available] | medium | 1 | 0 | organic heterobicyclic compound; organonitrogen heterocyclic compound; organosulfur heterocyclic compound | |
| 1-[2-(dimethylamino)ethyl]-5-methoxy-N-methyl-2-indolecarboxamide | [no description available] | medium | 1 | 0 | indolecarboxamide | |
| N-(5-ethyl-1,3,4-thiadiazol-2-yl)-3-methoxybenzamide | [no description available] | medium | 1 | 0 | benzamides | |
| 4-(1H-benzimidazol-2-yl)quinoline | [no description available] | medium | 1 | 0 | quinolines | |
| 1-(4-Chlorophenyl)-2-[(1-methyl-1H-imidazol-2-yl)thio]ethan-1-one | [no description available] | medium | 1 | 0 | aromatic ketone | |
| N-(2,5-dimethylphenyl)-2-benzofurancarboxamide | [no description available] | medium | 1 | 0 | aromatic amide; furans | |
| N-(4-methoxyphenyl)-2-benzofurancarboxamide | [no description available] | medium | 1 | 0 | aromatic amide; furans | |
| 2-(9h-xanthen-9-yl)-malonic acid | [no description available] | medium | 1 | 0 | xanthenes | |
| 1-(1,3-benzothiazol-2-yl)-3-phenylurea | [no description available] | medium | 1 | 0 | ureas | |
| 1-hydroxy-2-phenyl-1,5,6,7-tetrahydro-4H-benzimidazol-4-one | [no description available] | medium | 1 | 0 | imidazoles | |
| N-(4-acetamidophenyl)-2-bromobenzamide | [no description available] | medium | 1 | 0 | benzamides | |
| 4-bromo-N-phenacylbenzamide | [no description available] | medium | 1 | 0 | aromatic ketone | |
| 1-(2,3-dihydroindol-1-yl)-2-(phenylthio)ethanone | [no description available] | medium | 1 | 0 | indoles | |
| N-[6-methyl-2-(4-methylphenyl)-5-benzotriazolyl]-3-pyridinecarboxamide | [no description available] | medium | 1 | 0 | triazoles | |
| 2-(1-piperidinylmethyl)phenol | [no description available] | medium | 1 | 0 | ||
| 2,6-bis(benzimidazol-2-yl)pyridine | [no description available] | medium | 1 | 0 | benzimidazoles | |
| 1-cyclohexyl-3-(2-phenylethyl)urea | [no description available] | medium | 1 | 0 | benzenes | |
| 1-(3,5-dichlorophenyl)-3-phenylurea | [no description available] | medium | 1 | 0 | ureas | |
| 1-(cyclohexylmethyl)-4-phenylpiperazine | [no description available] | medium | 1 | 0 | piperazines | |
| N-phenethyl-2-furamide | [no description available] | medium | 1 | 0 | aromatic amide; heteroarene | |
| paromomycin sulfate | [no description available] | medium | 1 | 0 | ||
| N,N,2-trimethyl-1-phenyl-5-benzimidazolesulfonamide | [no description available] | medium | 1 | 0 | benzimidazoles | |
| N-(phenylmethyl)-4-(3-pyridinyl)-2-thiazolamine | [no description available] | medium | 1 | 0 | aralkylamine | |
| N-(4-hydroxy-2-methyl-5-propan-2-ylphenyl)benzenesulfonamide | [no description available] | medium | 1 | 0 | monoterpenoid | |
| 2-amino-5-ethyl-4-(2-furanyl)-6-propyl-3-pyridinecarbonitrile | [no description available] | medium | 1 | 0 | nitrile; pyridines | |
| 2-ethoxy-N-[5-(methoxymethyl)-1,3,4-thiadiazol-2-yl]benzamide | [no description available] | medium | 1 | 0 | benzamides | |
| vu0099704 | [no description available] | medium | 1 | 0 | ||
| 3-(4-chlorophenyl)-2,5-dimethyl-1H-pyrazolo[1,5-a]pyrimidin-7-one | [no description available] | medium | 1 | 0 | pyrazoles; ring assembly | |
| 1-(2-chloro-6-fluorophenyl)-[1,2,4]triazolo[4,3-a]quinoline | [no description available] | medium | 1 | 0 | triazoles | |
| 2-methyl-N-(1-methyl-2,3-dihydropyrrolo[2,3-b]quinolin-4-yl)propanamide | [no description available] | medium | 1 | 0 | pyrroloquinoline | |
| 2-methyl-5-[(2-methyl-4-quinolinyl)thio]-1,3,4-thiadiazole | [no description available] | medium | 1 | 0 | aryl sulfide | |
| 5-methyl-1-(4-nitrophenyl)-2-oxo-2,5-dihydro-1h-pyrido(3,2-b)indole-3-carbonitrile | [no description available] | medium | 1 | 0 | ||
| (3-hydroxy-5,6,7,8-tetrahydro-4H-cyclohepta[d]imidazol-2-yl)-phenylmethanone | [no description available] | medium | 1 | 0 | aromatic ketone | |
| 2-fluoro-N-phenacylbenzamide | [no description available] | medium | 1 | 0 | aromatic ketone | |
| 4-(methoxymethyl)-6-methyl-2-(2-methylanilino)-3-pyridinecarbonitrile | [no description available] | medium | 1 | 0 | nitrile; pyridines | |
| 1-azepanyl-[2-methoxy-4-(methylthio)phenyl]methanone | [no description available] | medium | 1 | 0 | carbonyl compound; thiol | |
| GS4012 free base | [no description available] | medium | 1 | 0 | aryl sulfide; monomethoxybenzene; pyridines | VEGF activator |
| N-[1-(4-methylphenyl)-5-benzimidazolyl]acetamide | [no description available] | medium | 1 | 0 | benzimidazoles | |
| 2-(4-methylanilino)-1-(4-nitrophenyl)ethanone | [no description available] | medium | 1 | 0 | aromatic ketone | |
| N-(2,6-dimethylphenyl)-N(2)-(3,5-dimethylphenyl)glycinamide | [no description available] | medium | 1 | 0 | amino acid amide; glycine derivative | |
| 2-[4-[(3-fluorophenyl)methyl]-1-piperazinyl]pyrimidine | [no description available] | medium | 1 | 0 | N-arylpiperazine | |
| 1-[(3,4-dimethoxyphenyl)methyl]-4-(2,3-dimethylphenyl)piperazine | [no description available] | medium | 1 | 0 | piperazines | |
| 4-Piperidinobenzoic acid | [no description available] | medium | 1 | 0 | piperidines | |
| 1-(2-methoxyphenyl)-4-(3-thiophenylmethyl)piperazine | [no description available] | medium | 1 | 0 | piperazines | |
| N-(1-methyl-2,3-dihydropyrrolo[2,3-b]quinolin-4-yl)-2-(1-pyrrolidinyl)acetamide | [no description available] | medium | 1 | 0 | pyrroloquinoline | |
| 4-[(1H-benzimidazol-2-ylthio)methyl]-2-thiazolamine | [no description available] | medium | 1 | 0 | benzimidazoles | |
| 4-[(4-phenyl-2-thiazolyl)amino]benzenesulfonamide | [no description available] | medium | 1 | 0 | sulfonamide | |
| N-[7-(1-oxopropyl)-2,3-dihydro-1,4-benzodioxin-6-yl]benzamide | [no description available] | medium | 1 | 0 | benzodioxine | |
| N-[3-chloro-4-(1-pyrrolidinyl)phenyl]-2-furancarboxamide | [no description available] | medium | 1 | 0 | aromatic amide; furans | |
| n-(pyridin-2-yl)-4-(pyridin-2-yl)thiazol-2-amine | [no description available] | medium | 1 | 0 | ||
| 8-(3,5-dimethyl-1-pyrazolyl)quinoline | [no description available] | medium | 1 | 0 | quinolines | |
| 2'-nitroflavone | [no description available] | medium | 1 | 0 | ||
| N-(4-methoxyphenyl)-3,4-dihydroquinolin-2-amine | [no description available] | medium | 1 | 0 | aminoquinoline | |
| 1-(3-nitrophenyl)-3-phenyl-2-propyn-1-one | [no description available] | medium | 1 | 0 | aromatic compound | |
| vrt 532 | [no description available] | medium | 1 | 0 | ||
| 4-[[4-(2,5-dimethylphenyl)-1-piperazinyl]methyl]-2-methoxyphenol | [no description available] | medium | 1 | 0 | piperazines | |
| 1-piperonylpiperidine | [no description available] | medium | 1 | 0 | ||
| 2-[(3-fluorophenyl)methyl-(phenylmethyl)amino]ethanol | [no description available] | medium | 1 | 0 | aromatic amine | |
| 2-methoxy-4-[[2-(methylthio)anilino]methyl]phenol | [no description available] | medium | 1 | 0 | aromatic amine | |
| 6-ethyl-5-methyl-2-thiophen-2-yl-1H-pyrazolo[1,5-a]pyrimidin-7-one | [no description available] | medium | 1 | 0 | pyrazolopyrimidine | |
| N-[4-(2-methyl-4-thiazolyl)phenyl]benzamide | [no description available] | medium | 1 | 0 | benzamides | |
| N-(6-phenyl-5-imidazo[2,1-b]thiazolyl)benzamide | [no description available] | medium | 1 | 0 | imidazoles | |
| 2-(phenylmethylthio)-6,7-dihydro-5H-pyrrolo[1,2-a]imidazole | [no description available] | medium | 1 | 0 | aryl sulfide | |
| 5-methyl-N-(4,5,6-trimethyl-2-pyrimidinyl)-1,3-benzoxazol-2-amine | [no description available] | medium | 1 | 0 | benzoxazole | |
| 1-(4-methoxyphenyl)-3-(6-methyl-2-pyridinyl)urea | [no description available] | medium | 1 | 0 | ureas | |
| 2-{[hydroxy(2-methoxyphenyl)methylidene]amino}acetic acid | [no description available] | medium | 1 | 0 | N-acylglycine | |
| (4-methoxyphenyl)-(3-methyl-2-propyl-4-imidazolyl)methanone | [no description available] | medium | 1 | 0 | aromatic ketone | |
| N-(3-acetamidophenyl)-2-chlorobenzamide | [no description available] | medium | 1 | 0 | benzamides | |
| N4,N4-dimethyl-N1-(4-nitro-1,1-dioxo-2,5-dihydrothiophen-3-yl)benzene-1,4-diamine | [no description available] | medium | 1 | 0 | dialkylarylamine; tertiary amino compound | |
| 2-bromo-N-(3-methoxyphenyl)benzamide | [no description available] | medium | 1 | 0 | benzamides | |
| 2-methoxy-4-[(4-methyl-1,4-diazepan-1-yl)methyl]-6-nitrophenol | [no description available] | medium | 1 | 0 | aromatic ether; C-nitro compound | |
| 3-[[(2,5-dimethyl-3-furanyl)-oxomethyl]amino]benzoic acid | [no description available] | medium | 1 | 0 | aromatic amide; furans | |
| 1-(4-ethoxyphenyl)-3-(6-quinoxalinyl)urea | [no description available] | medium | 1 | 0 | quinoxaline derivative | |
| 2-(dimethylsulfamoylamino)-9H-fluorene | [no description available] | medium | 1 | 0 | fluorenes | |
| 4-chloro-1-ethyl-3-nitro-2-quinolinone | [no description available] | medium | 1 | 0 | nitro compound; quinolines | |
| 4-chloro-3-nitro-1-(phenylmethyl)-2-quinolinone | [no description available] | medium | 1 | 0 | quinolines | |
| 2,5-dimethyl-1-(phenylmethyl)pyrrole-3,4-dicarboxaldehyde | [no description available] | medium | 1 | 0 | arenecarbaldehyde | |
| 2-(2-chloro-6-fluorophenyl)-1-(2,4-dihydroxyphenyl)ethanone | [no description available] | medium | 1 | 0 | stilbenoid | |
| 4-methyl-N-(3-nitrophenyl)-5-phenyl-3-thiophenecarboxamide | [no description available] | medium | 1 | 0 | aromatic amide | |
| N-(5-amino-1-phenyl-1,2,4-triazol-3-yl)-2,2,2-trichloroacetamide | [no description available] | medium | 1 | 0 | triazoles | |
| N-(2-fluoro-5-methylphenyl)-3-phenylpropanamide | [no description available] | medium | 1 | 0 | anilide | |
| N-[(4-fluorophenyl)methyl]-2-thiophen-2-ylacetamide | [no description available] | medium | 1 | 0 | organofluorine compound | |
| 4-tert-butyl-N-(1,4-dioxo-2,3-dihydrophthalazin-5-yl)benzamide | [no description available] | medium | 1 | 0 | phthalazines | |
| N-[2-(2-methylpropyl)-1,3-dioxo-5-isoindolyl]-2-furancarboxamide | [no description available] | medium | 1 | 0 | phthalimides | |
| 6-(1,4,5,7-tetramethyl-6-pyrrolo[3,4-d]pyridazinyl)quinoline | [no description available] | medium | 1 | 0 | quinolines | |
| 2-(3,4-dimethoxyphenyl)-1-(2,4,6-trihydroxyphenyl)ethanone | [no description available] | medium | 1 | 0 | stilbenoid | |
| 5-(3-chloro-4-methylphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole | [no description available] | medium | 1 | 0 | oxadiazole; ring assembly | |
| 5-(phenylmethyl)-3-(2-pyridinyl)-1,2,4-oxadiazole | [no description available] | medium | 1 | 0 | pyridines | |
| 2-methyl-5-(1-pyrrolidinyl)isoindole-1,3-dione | [no description available] | medium | 1 | 0 | phthalimides | |
| (2'-(4-aminophenyl)-(2,5'-bi-1h-benzimidazol)-5-amine) | [no description available] | medium | 1 | 0 | benzimidazoles | |
| N-(4-bromo-2-fluorophenyl)-2-methyl-3-furancarboxamide | [no description available] | medium | 1 | 0 | aromatic amide; furans | |
| 6,7,8,9-tetrahydro-5H-carbazole-3-carbohydrazide | [no description available] | medium | 1 | 0 | carbazoles | |
| N-(3-carbamoyl-4,5,6,7-tetrahydro-1-benzothiophen-2-yl)-2-pyrazinecarboxamide | [no description available] | medium | 1 | 0 | primary carboxamide; pyrazines; secondary carboxamide | |
| N-(1,3-benzodioxol-5-yl)-5-methyl-2-furancarboxamide | [no description available] | medium | 1 | 0 | benzodioxoles | |
| 1-cyclohexyl-3-(2,3-dihydro-1,4-benzodioxin-6-yl)urea | [no description available] | medium | 1 | 0 | benzodioxine | |
| 8-[(2-methyl-5-nitro-1,2,4-triazol-3-yl)thio]quinoline | [no description available] | medium | 1 | 0 | aryl sulfide | |
| 1-[2-(2-chlorophenoxy)ethyl]benzimidazole | [no description available] | medium | 1 | 0 | benzimidazoles | |
| 4,5-dimethyl-2-[4-(3-nitrophenyl)-2-thiazolyl]-1H-pyrazol-3-one | [no description available] | medium | 1 | 0 | C-nitro compound | |
| 2-(4-fluoro-N-methylsulfonylanilino)-N-(3-methylphenyl)acetamide | [no description available] | medium | 1 | 0 | sulfonamide | |
| 1-(4-fluorophenyl)-2-(2-pyridinylthio)ethanone | [no description available] | medium | 1 | 0 | aromatic ketone | |
| 3-methyl-6-(1-pyrrolidinyl)-[1,2,4]triazolo[4,3-b]pyridazine | [no description available] | medium | 1 | 0 | triazolopyridazine | |
| N-(3-acetylphenyl)-2-thiophen-2-ylacetamide | [no description available] | medium | 1 | 0 | aromatic ketone | |
| oncrasin-1 | [no description available] | medium | 1 | 0 | arenecarbaldehyde; indoles; monochlorobenzenes | antineoplastic agent; apoptosis inducer |
| N-[2-(4-fluorophenyl)ethyl]-4-nitrobenzamide | [no description available] | medium | 1 | 0 | C-nitro compound | |
| 5-(1-methyl-2-benzimidazolyl)-2-thiophenecarboxaldehyde | [no description available] | medium | 1 | 0 | benzimidazoles | |
| N-(4-anilinophenyl)-2-methylpropanamide | [no description available] | medium | 1 | 0 | anilide | |
| N-(2-fluorophenyl)-3-phenylpropanamide | [no description available] | medium | 1 | 0 | anilide | |
| 1-[(Phenylthio)acetyl]piperidine | [no description available] | medium | 1 | 0 | N-acylpiperidine | |
| N-(3-hydroxyphenyl)-5-methyl-3-furancarboxamide | [no description available] | medium | 1 | 0 | aromatic amide; furans | |
| 3-(4-methoxyphenyl)-5-(4-methylphenyl)-1,2,4-oxadiazole | [no description available] | medium | 1 | 0 | oxadiazole; ring assembly | |
| 4-[(4-carboxy-2,6-dimethoxyphenoxy)methyl]-5-methyl-2-furancarboxylic acid | [no description available] | medium | 1 | 0 | trihydroxybenzoic acid | |
| 4-(4-morpholinylmethyl)-3-quinolinol | [no description available] | medium | 1 | 0 | quinolines | |
| 2-bromo-N-[3-(1-oxopropylamino)phenyl]benzamide | [no description available] | medium | 1 | 0 | benzamides | |
| 3-acetyl-2-methylbenzo[f]benzofuran-4,9-dione | [no description available] | medium | 1 | 0 | naphthofuran | |
| 5-(4-chlorophenyl)-N-(5-ethyl-1,3,4-thiadiazol-2-yl)-2-furancarboxamide | [no description available] | medium | 1 | 0 | aromatic amide; heteroarene | |
| 1-azepanyl-[4-[(phenylthio)methyl]phenyl]methanone | [no description available] | medium | 1 | 0 | benzamides | |
| 1-(5-ethyl-2,4-dihydroxyphenyl)-2-(2-fluorophenoxy)ethanone | [no description available] | medium | 1 | 0 | aromatic ketone | |
| N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-(2-nitrophenyl)acetamide | [no description available] | medium | 1 | 0 | acetamides | |
| 3,4,5-triethoxy-N-(1H-1,2,4-triazol-5-yl)benzamide | [no description available] | medium | 1 | 0 | benzamides | |
| 1-propylsulfonyl-4-(2-pyridinyl)piperazine | [no description available] | medium | 1 | 0 | piperazines; pyridines | |
| 2-(2-phenylethylthio)-3-pyridinecarboxylic acid | [no description available] | medium | 1 | 0 | aromatic carboxylic acid; pyridines | |
| 2-(2,3-dimethylphenoxy)-N-pyridin-4-ylacetamide | [no description available] | medium | 1 | 0 | aromatic ether | |
| 2-[[anilino(oxo)methyl]amino]-N-(phenylmethyl)benzamide | [no description available] | medium | 1 | 0 | benzamides | |
| N-(5-acetyl-4-methyl-2-thiazolyl)-5-bromo-2-furancarboxamide | [no description available] | medium | 1 | 0 | thiazoles | |
| 1-cyclohexyl-3-(3-ethylphenyl)urea | [no description available] | medium | 1 | 0 | ureas | |
| n-phenylpiracetam | [no description available] | medium | 1 | 0 | ||
| 2-[(1-methyl-5-tetrazolyl)thio]-N-(2-phenylphenyl)acetamide | [no description available] | medium | 1 | 0 | biphenyls | |
| N-[3-chloro-4-(1-pyrrolidinyl)phenyl]-2-nitrobenzamide | [no description available] | medium | 1 | 0 | benzamides | |
| 4-(3,4-dihydro-1H-isoquinolin-2-ylmethyl)-N-(2,6-dimethylphenyl)benzamide | [no description available] | medium | 1 | 0 | isoquinolines | |
| 5-(4-bromophenyl)-N-(2-methoxyphenyl)-2-furancarboxamide | [no description available] | medium | 1 | 0 | aromatic amide; furans | |
| 3-[[(3,5-dichloro-4-ethoxyphenyl)-oxomethyl]amino]benzoic acid | [no description available] | medium | 1 | 0 | benzamides | |
| 1,4-bis(thiophen-2-ylsulfonyl)piperazine | [no description available] | medium | 1 | 0 | N-sulfonylpiperazine; thiophenes | |
| 2-bromo-N-[3-(1-oxobutylamino)phenyl]benzamide | [no description available] | medium | 1 | 0 | benzamides | |
| 1-(2-fluorophenyl)-4-[(6-nitro-1,3-benzodioxol-5-yl)methyl]piperazine | [no description available] | medium | 1 | 0 | piperazines | |
| n-(1-benzyl-4-piperidinyl)-2,4-dichlorobenzamide | [no description available] | medium | 1 | 0 | ||
| 2-[[2-(5-methyl-2-thiophenyl)-2-oxoethyl]thio]-3-phenyl-4-quinazolinone | [no description available] | medium | 1 | 0 | quinazolines | |
| 1-(2,1,3-benzothiadiazol-5-yl)-3-[4-(4-morpholinyl)phenyl]urea | [no description available] | medium | 1 | 0 | morpholines | |
| ethyl 4-{N-[(4-chlorophenyl)sulfonyl]-N-methylglycyl}piperazine-1-carboxylate | [no description available] | medium | 1 | 0 | carbamate ester; sulfonamide | |
| LSM-4563 | [no description available] | medium | 1 | 0 | aromatic ketone | |
| 1-(4-chloro-3-methoxyphenyl)sulfonyl-4-phenylpiperazine | [no description available] | medium | 1 | 0 | piperazines | |
| N-[4-[(3,4-dimethoxyphenyl)sulfamoyl]phenyl]acetamide | [no description available] | medium | 1 | 0 | sulfonamide | |
| 4-chloro-3-(1-piperidinylsulfonyl)-N-(2-thiazolyl)benzamide | [no description available] | medium | 1 | 0 | sulfonamide | |
| 1-(2,5-dimethoxyphenyl)sulfonyl-4-(phenylmethyl)piperazine | [no description available] | medium | 1 | 0 | sulfonamide | |
| 2-(4-methoxyphenyl)-N-[4-[(5-methyl-3-isoxazolyl)sulfamoyl]phenyl]acetamide | [no description available] | medium | 1 | 0 | sulfonamide | |
| 4-[4-(benzenesulfonyl)-1-piperazinyl]-2-methylquinoline | [no description available] | medium | 1 | 0 | piperazines; pyridines | |
| 1-(6-methoxy-2,2,4-trimethyl-1-quinolinyl)-2-[[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]thio]ethanone | [no description available] | medium | 1 | 0 | quinolines | |
| N2-phenyl-6-[[(1-phenyl-5-tetrazolyl)thio]methyl]-1,3,5-triazine-2,4-diamine | [no description available] | medium | 1 | 0 | tetrazoles | |
| 2-[(4,6-dimethyl-2-pyrimidinyl)thio]-N-(4,5-diphenyl-2-oxazolyl)acetamide | [no description available] | medium | 1 | 0 | 1,3-oxazoles | |
| 2-(4-bromophenyl)-1-[4-(2-pyridinyl)-1-piperazinyl]ethanone | [no description available] | medium | 1 | 0 | piperazines; pyridines | |
| 2-amino[1,3]thiazolo[4,5-d]pyrimidine-5,7-diol | [no description available] | medium | 1 | 0 | thiazolopyrimidine | |
| 3-[[(2-cyclohexyl-1,3-dioxo-5-isoindolyl)-oxomethyl]amino]benzoic acid | [no description available] | medium | 1 | 0 | aromatic amide | |
| 3-[[[3-(1-azepanylsulfonyl)-4-chlorophenyl]-oxomethyl]amino]benzoic acid | [no description available] | medium | 1 | 0 | benzamides | |
| 2-(4-bromophenyl)-N-(5-tert-butyl-1,3,4-thiadiazol-2-yl)acetamide | [no description available] | medium | 1 | 0 | acetamides | |
| 5-(1,3-benzodioxol-5-ylsulfamoyl)-2-methoxybenzoic acid | [no description available] | medium | 1 | 0 | methoxybenzoic acid | |
| N-cycloheptyl-1-(4-methylphenyl)sulfonyl-4-piperidinecarboxamide | [no description available] | medium | 1 | 0 | sulfonamide | |
| 3-(2-chlorophenyl)-5-methyl-N-[4-[2-(4-morpholinyl)-2-oxoethoxy]phenyl]-4-isoxazolecarboxamide | [no description available] | medium | 1 | 0 | aromatic amide | |
| N-[3-[[(4-nitrophenyl)-oxomethyl]amino]phenyl]-2-furancarboxamide | [no description available] | medium | 1 | 0 | benzamides | |
| 3-methyl-1,5-dithiophen-2-ylpentane-1,5-dione | [no description available] | medium | 1 | 0 | aromatic ketone | |
| N-(2-methyl-1,3-benzothiazol-6-yl)-4-(4-morpholinylsulfonyl)benzamide | [no description available] | medium | 1 | 0 | sulfonamide | |
| 4-(dimethylsulfamoyl)-N-(4-thiophen-2-yl-2-thiazolyl)benzamide | [no description available] | medium | 1 | 0 | sulfonamide | |
| 3-chloro-N-[4-[(1-oxo-2-phenylethyl)amino]phenyl]benzamide | [no description available] | medium | 1 | 0 | benzamides | |
| N-(3,4-dimethoxyphenyl)-4-[(4-phenyl-1-piperazinyl)methyl]benzamide | [no description available] | medium | 1 | 0 | benzamides | |
| stk295900 | [no description available] | medium | 1 | 0 | ||
| 1-(3-chlorophenyl)-4-[(3,4,5-trimethoxyphenyl)methyl]piperazine | [no description available] | medium | 1 | 0 | piperazines | |
| 2-[4-[[4-(4-methoxyphenyl)-1-phthalazinyl]amino]phenyl]acetamide | [no description available] | medium | 1 | 0 | pyridazines; ring assembly | |
| 1-(2-fluorophenyl)-3-[5-(2-fluorophenyl)-1,3,4-thiadiazol-2-yl]urea | [no description available] | medium | 1 | 0 | ureas | |
| N-[5-[(4-methoxyphenyl)methyl]-1,3,4-thiadiazol-2-yl]-2-furancarboxamide | [no description available] | medium | 1 | 0 | methoxybenzenes | |
| N-(1,3-benzodioxol-5-yl)-4-methyl-1-phthalazinamine | [no description available] | medium | 1 | 0 | phthalazines | |
| SMER 28 | [no description available] | medium | 1 | 0 | organobromine compound; quinazolines; secondary amino compound | autophagy inducer |
| N-[4-(4-morpholinyl)phenyl]carbamic acid butyl ester | [no description available] | medium | 1 | 0 | morpholines | |
| 4-(4-chlorophenoxy)-1-(4-morpholinyl)-1-butanone | [no description available] | medium | 1 | 0 | aromatic ether | |
| 4-(4-chlorophenoxy)-1-(1-piperidinyl)-1-butanone | [no description available] | medium | 1 | 0 | N-acylpiperidine | |
| N-(3-phenylpropyl)methanesulfonamide | [no description available] | medium | 1 | 0 | benzenes | |
| 4-acetamido-N-(2-methoxyethyl)benzamide | [no description available] | medium | 1 | 0 | amidobenzoic acid | |
| 2-methyl-N-(2,3,4,5,6-pentafluorophenyl)-3-furancarboxamide | [no description available] | medium | 1 | 0 | aromatic amide; furans | |
| 3,4-dihydro-2H-quinolin-1-yl-(4-propoxyphenyl)methanone | [no description available] | medium | 1 | 0 | quinolines | |
| 5-bromo-N-(2-phenylphenyl)-2-furancarboxamide | [no description available] | medium | 1 | 0 | aromatic amide; furans | |
| 2-[2-(4-chlorophenoxy)ethylthio]pyrimidine | [no description available] | medium | 1 | 0 | aromatic ether | |
| 3-(3-bromoanilino)-1-(5-methyl-2-furanyl)-1-propanone | [no description available] | medium | 1 | 0 | aralkylamine | |
| 4-[2-(4-bromo-2-chlorophenoxy)-1-oxoethyl]-1-piperazinecarboxylic acid ethyl ester | [no description available] | medium | 1 | 0 | piperazinecarboxylic acid | |
| 2-[2-[[3-(1,3-benzoxazol-2-yl)anilino]-oxomethyl]phenyl]benzoic acid | [no description available] | medium | 1 | 0 | benzamides | |
| 1-[2-(2-chlorophenoxy)ethoxy]-2-methoxy-4-methylbenzene | [no description available] | medium | 1 | 0 | methoxybenzenes | |
| N-[4-[(4-sulfamoylphenyl)sulfamoyl]phenyl]cyclopropanecarboxamide | [no description available] | medium | 1 | 0 | sulfonamide | |
| 4-[2-[2-(4-bromo-2-chlorophenoxy)ethoxy]ethyl]morpholine | [no description available] | medium | 1 | 0 | aromatic ether | |
| N-[2-(2-phenylphenoxy)ethyl]-2-furancarboxamide | [no description available] | medium | 1 | 0 | biphenyls | |
| 5,6,7,8-tetrafluoro-2-(2,3,4,5,6-pentafluorophenyl)-4h-1-benzopyran-4-one | [no description available] | medium | 1 | 0 | ||
| 2-[bis(5-methyl-2-furanyl)methyl]-6-nitrophenol | [no description available] | medium | 1 | 0 | nitrophenol | |
| 2-(4-nitrophenyl)-N-(2-oxolanylmethyl)-4-quinazolinamine | [no description available] | medium | 1 | 0 | quinazolines | |
| 2-(4-hydroxy-1,3-thiazol-2-yl)-1-phenylethan-1-one | [no description available] | medium | 1 | 0 | aromatic ketone | |
| Methyl(2-furoylamino)acetic acid | [no description available] | medium | 1 | 0 | N-acyl-amino acid | |
| 5-nitro-8-(1-pyrrolidinyl)quinoline | [no description available] | medium | 1 | 0 | nitro compound; quinolines | |
| 2-(3-oxo-2,4-dihydro-1H-quinoxalin-2-yl)-N-phenylacetamide | [no description available] | medium | 1 | 0 | amino acid amide | |
| 2-[(4-methylphenyl)sulfonylamino]pentanoic acid | [no description available] | medium | 1 | 0 | sulfonamide | |
| 4,6-dimorpholino-n-(4-nitrophenyl)-1,3,5-triazin-2-amine | [no description available] | medium | 1 | 0 | ||
| 1-[(3-chlorophenyl)methyl]-N,N-diethyl-3-piperidinecarboxamide | [no description available] | medium | 1 | 0 | piperidines | |
| 1-(2,6-dimethyl-1-piperidinyl)-2-phenylethanone | [no description available] | medium | 1 | 0 | acetamides | |
| 2-amino-7-methyl-5-oxo-4-(2,3,4-trimethoxyphenyl)-4,6,7,8-tetrahydro-1-benzopyran-3-carbonitrile | [no description available] | medium | 1 | 0 | methoxybenzenes | |
| 3-[4-(1,3-benzodioxol-5-ylmethyl)-1-piperazinyl]-1-phenylpyrrolidine-2,5-dione | [no description available] | medium | 1 | 0 | pyrrolidines | |
| 1-(4-bromophenyl)-3-(diethylamino)pyrrolidine-2,5-dione | [no description available] | medium | 1 | 0 | pyrrolidines | |
| 4-(5,6-diphenyl-1,2,4-triazin-3-yl)morpholine | [no description available] | medium | 1 | 0 | dialkylarylamine; tertiary amino compound | |
| (3,5-Dimethyl-1-adamantyl)amine nitrate | [no description available] | medium | 1 | 0 | nitrates | |
| 1-(4-tert-butylphenoxy)-3-(1H-1,2,4-triazol-5-ylthio)-2-propanol | [no description available] | medium | 1 | 0 | alkylbenzene | |
| N-[2-(1-methyl-2-pyrrolidinyl)ethyl]-2-adamantanamine | [no description available] | medium | 1 | 0 | N-alkylpyrrolidine | |
| 4-phenyl-N-(pyridin-4-ylmethyl)-2-butanamine | [no description available] | medium | 1 | 0 | aralkylamine | |
| N-(5-nitro-2-pyridinyl)cyclopropanecarboxamide | [no description available] | medium | 1 | 0 | aromatic amide | |
| 3-[(4-bromophenyl)methyl]-4-(4-methoxyanilino)-4-oxobutanoic acid | [no description available] | medium | 1 | 0 | anilide | |
| 3-ethyl-N-(2H-tetrazol-5-yl)-1-adamantanecarboxamide | [no description available] | medium | 1 | 0 | aromatic amide | |
| N-(4-propan-2-ylphenyl)-3-bicyclo[2.2.1]heptanecarboxamide | [no description available] | medium | 1 | 0 | monoterpenoid | |
| 4-chloro-N-[2-(4-nitroanilino)ethyl]benzamide | [no description available] | medium | 1 | 0 | carbonyl compound; organohalogen compound | |
| 2-[(2,3-dihydro-1,4-benzodioxin-6-ylamino)-oxomethyl]-1-cyclohexanecarboxylic acid | [no description available] | medium | 1 | 0 | benzodioxine | |
| 2,4-dichloro-6-[1-(4-morpholinyl)-3-phenylprop-2-ynyl]phenol | [no description available] | medium | 1 | 0 | aromatic compound | |
| 2-[[1-(4-ethoxyphenyl)-2,5-dioxo-3-pyrrolidinyl]amino]acetonitrile | [no description available] | medium | 1 | 0 | pyrrolidines | |
| 1-ethoxy-3-(2-methoxy-4-prop-2-enylphenoxy)-2-propanol | [no description available] | medium | 1 | 0 | methoxybenzenes | |
| 6-amino-4-(3-chlorophenyl)-3-methyl-1-(phenylmethyl)-4H-pyrano[2,3-c]pyrazole-5-carbonitrile | [no description available] | medium | 1 | 0 | organochlorine compound; pyranopyrazole | |
| 1-(2-chlorophenoxy)-3-(2-methyl-1-benzimidazolyl)-2-propanol | [no description available] | medium | 1 | 0 | benzimidazoles | |
| N-[2-furanyl-(8-hydroxy-7-quinolinyl)methyl]-2-methylpropanamide | [no description available] | medium | 1 | 0 | hydroxyquinoline | |
| N-(2-hydroxy-5-methylphenyl)-2-furancarboxamide | [no description available] | medium | 1 | 0 | aromatic amide; furans | |
| 4-amino-7,8,9,10-tetrahydro-6H-pyrimido[3,4]pyrrolo[3,5-a]azepine-11-carbonitrile | [no description available] | medium | 1 | 0 | organic heterobicyclic compound; organonitrogen heterocyclic compound | |
| 1-(3,5-dimethylphenyl)-3-(1H-1,2,4-triazol-5-ylthio)pyrrolidine-2,5-dione | [no description available] | medium | 1 | 0 | pyrrolidines | |
| 6-[(3,4-difluoroanilino)-oxomethyl]-1-cyclohex-3-enecarboxylic acid | [no description available] | medium | 1 | 0 | anilide | |
| 4-[(3-cyano-5,6,7,8-tetrahydro-4H-cyclohepta[b]thiophen-2-yl)amino]-4-oxobutanoic acid | [no description available] | medium | 1 | 0 | organosulfur heterocyclic compound | |
| [3-methyl-4-[oxo(thiophen-2-yl)methyl]-1-piperazinyl]-thiophen-2-ylmethanone | [no description available] | medium | 1 | 0 | aromatic amide; thiophenes | |
| [4-(2-methoxyphenyl)-1-piperazinyl]-[4-[(phenylthio)methyl]phenyl]methanone | [no description available] | medium | 1 | 0 | piperazines | |
| N-(3,3,5-trimethylcyclohexyl)-1H-1,2,4-triazole-5-carboxamide | [no description available] | medium | 1 | 0 | aromatic amide; heteroarene | |
| 4-[2-nitro-5-[4-(phenylmethyl)sulfonyl-1-piperazinyl]phenyl]morpholine | [no description available] | medium | 1 | 0 | piperazines | |
| 5-(4-ethylsulfonyl-1-piperazinyl)-2-nitro-N-(3-pyridinylmethyl)aniline | [no description available] | medium | 1 | 0 | piperazines | |
| 2-[[5-[(1,3-benzothiazol-2-ylthio)methyl]-4-methyl-1,2,4-triazol-3-yl]thio]-N-[2-(4-morpholinyl)ethyl]acetamide | [no description available] | medium | 1 | 0 | benzothiazoles | |
| N-ethyl-N-[2-[(5-nitro-8-quinolinyl)amino]ethyl]benzenesulfonamide | [no description available] | medium | 1 | 0 | nitro compound; quinolines | |
| 1-(4-methoxyphenyl)-N-(4-methyl-2-pyridinyl)-5-oxo-3-pyrrolidinecarboxamide | [no description available] | medium | 1 | 0 | pyrrolidines | |
| 3,4,5-trimethoxy-N-[4-[(2-methyl-1-piperidinyl)sulfonyl]phenyl]benzamide | [no description available] | medium | 1 | 0 | benzamides | |
| 3-(n,n-dimethylsulfonamido)-4-methyl-nitrobenzene | [no description available] | medium | 1 | 0 | C-nitro compound; sulfonamide; toluenes | bone density conservation agent; EC 3.1.4.53 (3',5'-cyclic-AMP phosphodiesterase) inhibitor; geroprotector |
| 6,3',4'-Trimethoxyflavanone | [no description available] | medium | 1 | 0 | ether; flavonoids | |
| 1-[4-(3-ethoxyphenoxy)butyl]imidazole | [no description available] | medium | 1 | 0 | aromatic ether | |
| 5-[[(1-cyclohexyl-5-tetrazolyl)thio]methyl]-3-phenyl-1,2,4-oxadiazole | [no description available] | medium | 1 | 0 | oxadiazole; ring assembly | |
| 2-[1-(3,4-dihydro-2H-quinolin-1-yl)-1-oxopropan-2-yl]isoindole-1,3-dione | [no description available] | medium | 1 | 0 | phthalimides | |
| [4-(benzenesulfonyl)-1-piperazinyl]-(1-piperidinyl)methanone | [no description available] | medium | 1 | 0 | sulfonamide | |
| 3-(2,5-dioxo-1-pyrrolidinyl)-N-(2-methyl-1,3-dioxo-5-isoindolyl)benzamide | [no description available] | medium | 1 | 0 | amidobenzoic acid | |
| 6-[[[5-(ethylthio)-1,3,4-thiadiazol-2-yl]amino]-oxomethyl]-1-cyclohex-3-enecarboxylic acid | [no description available] | medium | 1 | 0 | aromatic amide | |
| 2,5-dimethoxy-n-(quinolin-3-yl)benzenesulfonamide | [no description available] | medium | 1 | 0 | quinolines | |
| LSM-25805 | [no description available] | medium | 1 | 0 | isoindoles | |
| 4-ethoxy-N-(3-quinolinyl)benzenesulfonamide | [no description available] | medium | 1 | 0 | quinolines | |
| 3-chloro-N-[3-(1-imidazolyl)propyl]-6-nitro-1-benzothiophene-2-carboxamide | [no description available] | medium | 1 | 0 | 1-benzothiophenes | |
| nsc 727447 | [no description available] | medium | 1 | 0 | ||
| 2-methoxy-N-[(4-methylphenyl)methyl]-2-phenylacetamide | [no description available] | medium | 1 | 0 | acetamides | |
| 2-(4-chlorophenoxy)-N-(5-nitro-2-thiazolyl)acetamide | [no description available] | medium | 1 | 0 | C-nitro compound; thiazoles | |
| 7-(2-methoxyphenyl)-5-phenyl-1,7-dihydrotetrazolo[1,5-a]pyrimidine | [no description available] | medium | 1 | 0 | methoxybenzenes | |
| N-[3-[2,5-dioxo-3-(phenylmethyl)-1-pyrrolidinyl]phenyl]acetamide | [no description available] | medium | 1 | 0 | pyrrolidines | |
| 3,4-dimethoxy-N-[3-(methylthio)phenyl]benzenesulfonamide | [no description available] | medium | 1 | 0 | sulfonamide | |
| 3-methyl-4-nitro-N-(1H-1,2,4-triazol-5-yl)benzamide | [no description available] | medium | 1 | 0 | C-nitro compound | |
| 2-[(4-chlorophenyl)methylthio]-N-(2-hydroxy-5-nitrophenyl)acetamide | [no description available] | medium | 1 | 0 | nitrophenol | |
| 2-(4-ethoxyphenyl)-N-[3-(1-imidazolyl)propyl]-4-quinolinecarboxamide | [no description available] | medium | 1 | 0 | quinolines | |
| N-(4-bromophenyl)-5-methyl-4-nitro-1H-pyrazol-3-amine | [no description available] | medium | 1 | 0 | C-nitro compound | |
| 3,3-bis(4-hydroxyphenyl)-7-methyl-1,3-dihydro-2h-indol-2-one | [no description available] | medium | 1 | 0 | ||
| N-[4-[(cyclohexylamino)-oxomethyl]phenyl]-3-pyridinecarboxamide | [no description available] | medium | 1 | 0 | aromatic amide | |
| N,N,4-trimethyl-2-[[(5-methyl-2-furanyl)-oxomethyl]amino]-5-thiazolecarboxamide | [no description available] | medium | 1 | 0 | aromatic amide; thiazoles | |
| ex 527 | [no description available] | medium | 1 | 0 | carbazoles; monocarboxylic acid amide; organochlorine compound | |
| 3-[3-[(5-ethyl-[1,2,4]triazino[5,6-b]indol-3-yl)thio]propyl]-1H-benzimidazol-2-one | [no description available] | medium | 1 | 0 | indoles | |
| 4-methyl-2,7-diphenyl-8H-pyrido[2,3-d]pyrimidin-5-one | [no description available] | medium | 1 | 0 | phenylpyridine | |
| 3-methylharman | [no description available] | medium | 1 | 0 | ||
| 1-methyl-beta-carboline-3-carboxylic acid | [no description available] | medium | 1 | 0 | ||
| sildenafil | [no description available] | medium | 1 | 0 | piperazines; pyrazolopyrimidine; sulfonamide | EC 3.1.4.35 (3',5'-cyclic-GMP phosphodiesterase) inhibitor; vasodilator agent |
| 2-methyl-4(3h)-quinazolinone | [no description available] | medium | 1 | 0 | ||
| n(4)-desoxychlordiazepoxide | [no description available] | medium | 1 | 0 | ||
| 2-amino-3-hydroxyphenazine | [no description available] | medium | 1 | 0 | ||
| 2-styrylquinazolin-4(3h)-one | [no description available] | medium | 1 | 0 | ||
| 2-amino-5-iodo-6-phenyl-4-pyrimidinone | [no description available] | medium | 1 | 0 | ||
| quininib | [no description available] | medium | 1 | 0 | phenols; styrylquinoline | angiogenesis inhibitor |
| bropirimine | [no description available] | medium | 1 | 0 | pyrimidines | |
| 2-[(6-ethyl-4-methyl-2-quinazolinyl)amino]-1H-quinazolin-4-one | [no description available] | medium | 1 | 0 | quinazolines | |
| 2-[(6-ethyl-4-methyl-2-quinazolinyl)amino]-6-(methoxymethyl)-1H-pyrimidin-4-one | [no description available] | medium | 1 | 0 | quinazolines | |
| ampyrone | [no description available] | low | 0 | 0 | primary amino compound; pyrazolone | antipyretic; antirheumatic drug; drug metabolite; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; marine xenobiotic metabolite; non-narcotic analgesic; non-steroidal anti-inflammatory drug; peripheral nervous system drug |
| carbamazepine epoxide | [no description available] | low | 0 | 0 | dibenzoazepine; epoxide; ureas | allergen; drug metabolite; marine xenobiotic metabolite |
| clofibric acid | [no description available] | low | 0 | 0 | aromatic ether; monocarboxylic acid; monochlorobenzenes | anticholesteremic drug; antilipemic drug; antineoplastic agent; herbicide; marine xenobiotic metabolite; PPARalpha agonist |
| 5H-dibenzo[b,f]azepine | [no description available] | low | 0 | 0 | dibenzoazepine; mancude organic heterotricyclic parent | marine xenobiotic metabolite |
| 2-aminobenzimidazole | [no description available] | low | 0 | 0 | benzimidazoles | marine xenobiotic metabolite |
| diazoxon | [no description available] | low | 0 | 0 | organic phosphate; pyrimidines | marine xenobiotic metabolite |
| 6-deisopropylatrazine | [no description available] | low | 0 | 0 | chloro-1,3,5-triazine; diamino-1,3,5-triazine | bacterial xenobiotic metabolite; marine xenobiotic metabolite |
| 2,6-dichlorobenzamide | [no description available] | low | 0 | 0 | benzamides; dichlorobenzene | herbicide; marine xenobiotic metabolite |
| 3,4-dichlorophenylurea | [no description available] | low | 0 | 0 | dichlorobenzene; phenylureas | marine xenobiotic metabolite |
| methiocarb sulfoxide | [no description available] | low | 0 | 0 | carbamate ester; sulfoxide | marine xenobiotic metabolite |
| 5-methoxyindoleacetic acid | [no description available] | low | 0 | 0 | aromatic ether; indole-3-acetic acids | antibacterial agent; Brassica napus metabolite; carcinogenic agent; human urinary metabolite; marine xenobiotic metabolite; rat metabolite |
| 4-deethylatrazine | [no description available] | low | 0 | 0 | chloro-1,3,5-triazine; diamino-1,3,5-triazine | marine xenobiotic metabolite |
| 3,5,6-trichloro-2-pyridinol | [no description available] | low | 0 | 0 | chloropyridine; hydroxypyridine; pyridone | human urinary metabolite; human xenobiotic metabolite; marine xenobiotic metabolite |
| 3-phenoxybenzylalcohol | [no description available] | low | 0 | 0 | aromatic ether; benzyl alcohols | marine xenobiotic metabolite |
| u 40481 | [no description available] | low | 0 | 0 | benzenes; formamidines | marine xenobiotic metabolite |
| 2-aminosulfonyl-benzoic acid methyl ester | [no description available] | low | 0 | 0 | benzoate ester; methyl ester; sulfonamide | marine xenobiotic metabolite |
| fenofibric acid | [no description available] | low | 0 | 0 | aromatic ketone; chlorobenzophenone; monocarboxylic acid | drug metabolite; marine xenobiotic metabolite |
| n(4)-acetylsulfamethoxazole | [no description available] | low | 0 | 0 | isoxazoles; sulfonamide | drug metabolite; marine xenobiotic metabolite |
| n-acetylaminoantipyrine | [no description available] | low | 0 | 0 | acetamides; pyrazoles | drug metabolite; marine xenobiotic metabolite |
| N(4)-acetylsulfathiazole | [no description available] | low | 0 | 0 | 1,3-thiazoles; acetamides; sulfonamide | marine xenobiotic metabolite |
| 4-trifluoromethylphenol | [no description available] | low | 0 | 0 | (trifluoromethyl)benzenes; phenols | drug metabolite; marine xenobiotic metabolite |
| 4-formylaminoantipyrine | [no description available] | low | 0 | 0 | formamides; pyrazolone | drug metabolite; marine xenobiotic metabolite |
| ritalinic acid | [no description available] | low | 0 | 0 | monocarboxylic acid; piperidines | drug metabolite; marine xenobiotic metabolite |
| 2-(3,4-dimethoxyphenyl)-5-amino-2-isopropylvaleronitrile | [no description available] | low | 0 | 0 | dimethoxybenzene; nitrile; secondary amino compound | drug metabolite; marine xenobiotic metabolite |
| desethylterbuthylazine | [no description available] | low | 0 | 0 | chloro-1,3,5-triazine; diamino-1,3,5-triazine | marine xenobiotic metabolite |
| desvenlafaxine | [no description available] | low | 0 | 0 | cyclohexanols; phenols; tertiary amino compound | antidepressant; drug metabolite; marine xenobiotic metabolite |
| n(4)-acetylsulfadimethoxine | [no description available] | low | 0 | 0 | acetamides; pyrimidines; sulfonamide | marine xenobiotic metabolite |
| benzoylecgonine | [no description available] | low | 0 | 0 | benzoate ester; tropane alkaloid | epitope; human xenobiotic metabolite; marine xenobiotic metabolite; plant metabolite |
| gs 4071 | [no description available] | low | 0 | 0 | acetate ester; amino acid; cyclohexenecarboxylic acid; primary amino compound | antiviral drug; EC 3.2.1.18 (exo-alpha-sialidase) inhibitor; marine xenobiotic metabolite |
| 3-amino-5-morpholinomethyl-2-oxazolidinone | [no description available] | low | 0 | 0 | morpholines; oxazolidinone | marine xenobiotic metabolite; xenobiotic metabolite |
| fipronil sulfone | [no description available] | low | 0 | 0 | (trifluoromethyl)benzenes; dichlorobenzene; nitrile; pyrazoles; sulfone | marine xenobiotic metabolite |
| n,o-didesmethylvenlafaxine | [no description available] | low | 0 | 0 | cyclohexanols; phenols; secondary amino compound | drug metabolite; marine xenobiotic metabolite |
| n-desmethylvenlafaxine | [no description available] | low | 0 | 0 | cyclohexanols; monomethoxybenzene; secondary amino compound | drug metabolite; marine xenobiotic metabolite |
| clopidogrel carboxylic acid | [no description available] | low | 0 | 0 | monocarboxylic acid; monochlorobenzenes; tertiary amino compound; thienopyridine | drug metabolite; marine xenobiotic metabolite |
| 11-ketotestosterone | [no description available] | low | 0 | 0 | 11-oxo steroid; 17beta-hydroxy steroid; 3-oxo-Delta(4) steroid; androstanoid | androgen; human metabolite; marine xenobiotic metabolite |
| vitamin a2 | [no description available] | low | 0 | 0 | retinoid; vitamin A | human xenobiotic metabolite; marine xenobiotic metabolite; mouse metabolite |
| 2-hydroxyatrazine | [no description available] | low | 0 | 0 | diamino-1,3,5-triazine; monohydroxy-1,3,5-triazine | human xenobiotic metabolite; marine xenobiotic metabolite |
| g 27550 | [no description available] | low | 0 | 0 | hydroxypyrimidine; pyrimidone | marine xenobiotic metabolite |
| n-dichlorofluoromethylthio-n',n'-dimethyl-n-p-tolylsulfamide | [no description available] | low | 0 | 0 | organochlorine compound; organofluorine compound; phenylsulfamide fungicide; sulfamides | antifungal agrochemical; genotoxin |
| dichlofluanid | [no description available] | low | 0 | 0 | organochlorine compound; organofluorine compound; phenylsulfamide fungicide; sulfamides | acaricide; antifungal agrochemical |
| mesulergine | [no description available] | low | 0 | 0 | ergot alkaloid; sulfamides | antiparkinson drug; dopamine agonist; serotonergic antagonist |
| sulfamide | [no description available] | low | 0 | 0 | sulfamides | |
| cyazofamid | [no description available] | low | 0 | 0 | imidazole fungicide; imidazoles; nitrile; organochlorine compound; sulfamides; sulfonamide fungicide | antifungal agrochemical; mitochondrial cytochrome-bc1 complex inhibitor |
| macitentan | [no description available] | low | 0 | 0 | aromatic ether; organobromine compound; pyrimidines; ring assembly; sulfamides | antihypertensive agent; endothelin receptor antagonist; orphan drug |
| ro5126766 | [no description available] | low | 0 | 0 | aryloxypyrimidine; coumarins; organofluorine compound; pyridines; sulfamides | antineoplastic agent; EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor |
| act-132577 | [no description available] | low | 0 | 0 | aromatic ether; organobromine compound; pyrimidines; sulfamides | antihypertensive agent; drug metabolite; endothelin receptor antagonist; xenobiotic metabolite |
| Condition | Indicated | Relationship Strength | Studies | Trials |
|---|---|---|---|---|
| Anemia, Fanconi | 0 | low | 1 | 0 |
| Fanconi Anemia | 0 | low | 1 | 0 |
| Fanconi Hypoplastic Anemia | 0 | low | 1 | 0 |
| Fanconi Pancytopenia | 0 | low | 1 | 0 |
| Fanconi Panmyelopathy | 0 | low | 1 | 0 |
| Fanconi's Anemia | 0 | low | 1 | 0 |
| Inflammation | 0 | low | 1 | 0 |
| Innate Inflammatory Response | 0 | low | 1 | 0 |
| Malaria, Falciparum | 0 | low | 1 | 0 |
| Plasmodium falciparum Malaria | 0 | low | 1 | 0 |